Nuclear Medicine News

The effects of a water leak that caused a nuclear plant in Canada to shut down earlier this year are trickling down to Chippewa Valley hospitals.

A new study published in the July issue of The Journal of Nuclear Medicine shows that positron emission tomography scans in mice can be used to determine whether a novel type of breast cancer treatment is working as intended.

There's a good reason Dr. Michael Graham is the new president of an international scientific and medical organization.

The results were presented at SNM's 56th Annual Meeting. Early, accurate diagnosis of dementia is critical for providing the best available courses of treatment and therapies in the beginning stages of disease, when treatments can be most effective.

University of Iowa Director of Nuclear Medicine Michael Graham has been named the president of SNM, an international organization specializing in molecular imaging.

Molecular Insight Pharmaceuticals, Inc. today presented clinical data on a radiolabeled, small-molecule molecular imaging pharmaceutical in development for diagnosis and staging of prostate cancer at the 2009 annual meeting of the Society of Nuclear Medicine in Toronto.

The skin patch, which delivers the radioactive phosphorus-32, is nontoxic and could be an excellent alternative to surgery or radiotherapy in cases where carrying out these treatments is difficult.

Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today announced that epratuzumab labeled with the potent radioisotope, yttrium-90 , when given in small fractionated doses to patients with non-Hodgkin's lymphoma , achieved high rates of durable responses at ...

Main Category: Neurology / Neuroscience Also Included In: Radiology / Nuclear Medicine Article Date: 18 Jun 2009 An imaging agent used during PET scans to highlight apoptosis appears to help oncologists detect the effect of radiation treatment on brain metastases early in treatment, according to new data presented at the 56th Annual Meeting of the ...

Jun 16, 2009 - QuantRx Biomedical Corporation , a broad-based diagnostic company focused on the development and commercialization of innovative diagnostic products, today announced that its affiliate, FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, will present Phase I data relating to the safety, dosimetry, and ...

June 16, 2009 09:18 AM - Calling it one of the biggest crises in the history of the profession, the head of an international nuclear medicine group says the shutdown of Atomic Energy of Canada's Chalk River reactor last month is forcing "several thousand" heart and cancer scans a day to be cancelled or moved to the United States.

Main Category: Neurology / Neuroscience Also Included In: Cancer / Oncology ; Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 17 Jun 2009 - 3:00 PDT Peregrine Pharmaceuticals, Inc.

Some nuclear medicine physicians are expressing concern about the selection of one of their peers as special adviser to the health minister on the isotope shortage.

With domestic pressure building for the United States to quit Canada's erratic supply of medical isotopes, the Harper government is to announce Tuesday new funding for nuclear medicine, a day after Liberals vowed to defeat it unless it reveals a plan to end the crisis.

Reuters reports that "a North American shortage of medical isotopes has forced many U.S. hospitals to begin rationing scores of diagnostic tests, and doctors said on Friday they see no quick solution." The shortage is due to last month's shut down of a "nuclear reactor in eastern Ontario that produces a third of the world's supply of medical ...

The Society of Nuclear Medicine says the shortage of medical isotopes has left doctors "scrambling" and patients with the prospect of more invasive and costly procedures.

Immunomedics, Inc. , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer and other serious diseases, today reported that TF2, a proprietary pretargeting antibody, produced tumor-specific PET imaging and prolonged survival in a human colorectal cancer model.

FluoroPharma To Present Phase I Study Results Of Novel Positron Emission Tomography Myocardial Perfusion Imaging Tracer Main Category: Cardiovascular / Cardiology Also Included In: MRI / PET / Ultrasound Clinical Trials / Drug Trials FluoroPharma Inc., a company developing breakthrough PET molecular imaging agents, announced that it will present ...

A new study shows that a radioactive skin patch can safely and successfully treat basal cell carcinoma, one of the most common types of skin cancers, according to researchers at the SNM's 56th Annual Meeting.

OPINION By STEPHEN BROZAK and LARRY JINDRA, M.D. June 15, 2009 It is time to add a new phrase to the dictionary of disasters: Technetium-99 -- also known as Tech-99 or Tc99m.